补救性未成熟卵母细胞体外成熟与双卵巢刺激在预后不良女性中的贡献比较
该前瞻性队列研究纳入146例预后不良女性,比较补救性IVM(n=50)与双卵巢刺激(DuoStim,n=96)获取卵母细胞和可移植胚胎的效率。DuoStim黄体期刺激的成熟卵率、可用胚胎率和优质胚胎率均显著高于补救性IVM的未成熟卵母细胞(P<0.05)。DuoStim使无卵母细胞或可用胚胎的周期取消率从30.21%降至9.38%(P<0.001),而补救性IVM从24.00%降至12.00%但无显著差异。
要点
- DuoStim黄体期刺激获得的成熟卵、可用胚胎和优质胚胎比例显著高于补救性IVM。
- DuoStim显著降低无卵母细胞或可用胚胎的周期取消率(30.21%降至9.38%)。
- 补救性IVM可使周期取消率从24.00%降至12.00%,但差异无统计学意义。
核心结论
- 补救性IVM和DuoStim均可在最短时间内为预后不良女性提供更多成熟卵母细胞和可用胚胎,其中DuoStim可能更高效。
研究设计与样本
- 前瞻性队列研究,纳入2015年12月至2018年2月间146例预后不良女性,其中补救性IVM组50例,DuoStim组96例。
主要发现
- DuoStim组黄体期刺激的成熟卵率、可用胚胎率和优质胚胎率均显著高于补救性IVM组未成熟卵母细胞(P<0.05)。
- DuoStim组黄体期刺激对成熟卵、可用胚胎和优质胚胎的相对贡献均显著高于补救性IVM组(P<0.001)。
- DuoStim组无卵母细胞或可用胚胎的总体取消率从30.21%显著降至9.38%(P<0.001)。
- 补救性IVM组未成熟同胞卵母细胞体外成熟后,取消率从24.00%降至12.00%,但无显著差异。
临床怎么用
- 对于预后不良女性,可考虑DuoStim以在单个月经周期内获取更多成熟卵母细胞和可用胚胎。
- 补救性IVM可作为备选策略,但其效率可能低于DuoStim。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Maximizing the number of oocytes and embryos obtained in the shortest possible time is of considerable potential clinical significance for women with poor prognosis. The aim of this study was to develop a clinically applicable strategy to obtain more oocytes and viable embryos in one menstrual cycle for poor-prognosis women. DESIGN: Prospective cohort study of 146 women with poor prognosis who received rescue in-vitro maturation (IVM) (n = 50) or double ovarian stimulation (DuoStim) (n = 96) between December 2015 and February 2018. Outcomes, number of oocytes retrieved and matured, and embryo developmental potential were compared between the two groups. RESULTS: The rates of mature oocytes, available embryos and top-quality embryos from luteal phase stimulation (LPS) of DuoStim were all significantly higher than those derived from the immature oocytes of rescue IVM (P < 0.05). The relative contributions of LPS in the DuoStim group for proportion of mature oocytes, available embryos and top-quality embryos were all significantly higher than IVM in the rescue IVM group (P < 0.001). The overall cancellation rate of no oocyte or available embryo significantly decreased from 30.21% to 9.38% (P < 0.001) when DuoStim was carried out, which decreased from 24.00% to 12.00% with no significant difference in the rescue IVM group when immature sibling oocytes were matured in vitro. CONCLUSION: Rescue IVM and DuoStim can contribute more competent oocytes and viable embryos in the shortest possible time for poor-prognosis women, of which DuoStim may be more efficient.
引用
- Liu Y, Jiang H, Du X, et al. Contribution of rescue in-vitro maturation versus double ovarian stimulation in ovarian stimulation cycles of poor-prognosis women. Reprod Biomed Online. 2019. PMID: 32199798. doi:10.1016/j.rbmo.2019.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。